Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal

Area of Science:

• Cardiology
• Neurology
• Clinical Risk Assessment

Background:

• Atrial fibrillation (AF) substantially elevates stroke risk, necessitating proactive stroke prevention strategies.
• Effective management hinges on individualizing oral anticoagulation (OAC) therapy based on stroke and bleeding risk assessments.

Purpose of the Study:

• To provide a comprehensive overview of available stroke and bleeding risk stratification scores for patients with atrial fibrillation.
• To critically appraise these scores, including the risk factors and scoring methodologies employed.
• To summarize current international guideline recommendations for risk stratification in AF management.

Main Methods:

• Systematic review of identified stroke and bleeding risk factors, encompassing clinical, imaging, and biomarker data.
• Analysis of various risk stratification scores, detailing their components and scoring mechanisms.
• Critical appraisal of existing scores and discussion of emerging risk factors and modifiers, such as female sex.

Main Results:

• Numerous risk factors for stroke and bleeding in AF patients have been identified, leading to the development of multiple risk stratification scores.
• The review critically evaluates the strengths and limitations of these scores.
• Current major international guidelines recommend specific stroke and bleeding risk stratification scores for clinical use.

Conclusions:

• Accurate stroke and bleeding risk assessment is crucial for optimizing OAC therapy in atrial fibrillation.
• The dynamic nature of risk necessitates periodic re-evaluation to ensure treatment efficacy and patient safety.
• Understanding and applying recommended risk stratification tools are essential for evidence-based stroke prevention in AF.